Catalent, Inc. , a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders held earlier today, its.
(Reuters) - Catalent said on Wednesday its stockholders have voted to approve Novo Nordisk parent's $16.5 billion bid to take over the contract manufacturer. In February, Novo Holdings had agreed to buy Catalent, a key manufacturing subcontractor o.
J&J scoops up another atopic dermatitis drug for $1 25B fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.